KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Levi Strauss (LEVI) Asset Writedowns and Impairment (2016 - 2025)

Levi Strauss (LEVI) has disclosed Asset Writedowns and Impairment for 14 consecutive years, with -$7.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to -$7.2 million, compared with a TTM value of $2.5 million through Nov 2025, down 96.91%, and an annual FY2025 reading of $2.5 million, down 97.86% over the prior year.
  • Asset Writedowns and Impairment was -$7.2 million for Q4 2025 at Levi Strauss, down from $7.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $75.3 million in Q3 2023 and bottomed at -$36.1 million in Q4 2022.
  • Average Asset Writedowns and Impairment over 5 years is $10.7 million, with a median of $5.5 million recorded in 2024.
  • Peak annual rise in Asset Writedowns and Impairment hit 4174.07% in 2021, while the deepest fall reached 312.98% in 2021.
  • Year by year, Asset Writedowns and Impairment stood at -$12.8 million in 2021, then crashed by 180.63% to -$36.1 million in 2022, then surged by 308.86% to $75.3 million in 2023, then crashed by 92.7% to $5.5 million in 2024, then crashed by 230.91% to -$7.2 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for LEVI at -$7.2 million in Q4 2025, $7.2 million in Q2 2025, and $2.5 million in Q1 2025.